Literature DB >> 29768593

[Musculoskeletal pain among bus drivers and fare collectors in the Metropolitan Region of Belo Horizonte, Brazil].

Mariana Roberta Lopes Simões1, Ada Ávila Assunção2, Adriane Mesquita de Medeiros2.   

Abstract

Musculoskeletal pain among professionals in the transport sector has been linked to working conditions. The scope of this study was to assess the prevalence of cervical musculoskeletal pain and its relation to pain in other areas (arms, hands and shoulders). The association between neck pain, related to pain in other areas or otherwise, was checked against occupational factors. A cross-sectional, descriptive and analytical study was conducted with 799 bus drivers and 708 fare collectors of the Metropolitan Region of Belo Horizonte, Brazil. The outcome was characterized according to the positive answer to the question about musculoskeletal pain in the anatomical areas studied. The prevalence of neck pain in the sample was highest at 16.3%, followed by pain in the shoulders 15.4%, arms 13.3% and hands 6.3%. The factors associated with musculoskeletal pain in the sample were being female, complaints of disability, perception of threat to safety, vibration, excessive or unbearable noise and sitting in an uncomfortable posture. The results provide clues to transformation of the workplace, thereby contributing to the enhancement of occupational health.

Entities:  

Mesh:

Year:  2018        PMID: 29768593     DOI: 10.1590/1413-81232018235.13542016

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  2 in total

1.  Sick leave due to dorsopathies among bus drivers from a company in São Paulo, Brazil.

Authors:  Andrea Tomanik de Azevedo; Vinicius de Lima Benedito; João Silvestre Silva-Junior
Journal:  Rev Bras Med Trab       Date:  2022-06-30

2.  The burden of low back pain, rheumatoid arthritis, osteoarthritis, and gout and their respective attributable risk factors in Brazil: results of the GBD 2017 study.

Authors:  Juliana Wolf; Elisabeth Barboza França; Ada Ávila Assunção
Journal:  Rev Soc Bras Med Trop       Date:  2022-01-28       Impact factor: 1.581

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.